Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized Trial.

Petit A, Ducassou S, Leblanc T, Pasquet M, Rousseau A, Ragu C, Cachanado M, Nelken B, Bertrand Y, Michel G, Gandemer V, Cuccuini W, Fenneteau O, Lapillonne H, Auvrignon A, Baruchel A, Leverger G.

Hemasphere. 2018 Nov 29;2(6):e159. doi: 10.1097/HS9.0000000000000159. eCollection 2018 Dec.

PMID:
31723797
2.

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency.

Coignard-Biehler H, Mahlaoui N, Pilmis B, Barlogis V, Brosselin P, De Vergnes N, Debré M, Malphettes M, Frange P, Catherinot E, Pellier I, Durieu I, Perlat A, Royer B, Le Quellec A, Jeziorski E, Fischer A, Lortholary O; CEREDIH French PID study group, Aaron L, Adoue D, Aguilar C, Aladjidi N, Alcais A, Amoura Z, Arlet P, Armari-Alla C, Bader-Meunier B, Bayart S, Bertrand Y, Bienvenu B, Blanche S, Bodet D, Bonnotte B, Borie R, Boutard P, Briandet C, Brion JP, Brouard J, Cohen-Beaussant S, Costes L, Couderc LJ, Cougoul P, Courteille V, de Saint Basile G, Devoldere C, Deville A, Donadieu J, Dore E, Dulieu F, Edan C, Entz-Werle N, Fieschi C, Forestier A, Fouyssac F, Gajdos V, Galicier L, Gandemer V, Gardembas M, Gaud C, Guillerm G, Hachulla E, Hamidou M, Hermine O, Hoarau C, Humbert S, Jaccard A, Jacquot S, Jais JP, Jaussaud R, Jeandel PY, Kebaili K, Korganow AS, Lambotte O, Lanternier F, Larroche C, Lascaux AS, Le Moigne E, Le Moing V, Lebranchu Y, Lecuit M, Lefevre G, Lemal R, Te VLT, Marie-Cardine A, Silva NM, Masseau A, Massot C, Mazingue F, Merlin E, Michel G, Millot F, Monlibert B, Monpoux F, Moshous D, Mouthon L, Munzer M, Neven B, Nove-Josserand R, Oksenhendler E, Ouachée-Chardin M, Oudot C, Pagnier A, Pasquali JL, Pasquet M, Perel Y, Picard C, Piguet C, Plantaz D, Provot J, Quartier P, Rieux-Laucat F, Roblot P, Roger PM, Rohrlich PS, Rubie H, Salle V, Sarrot-Reynauld F, Servettaz A, Stephan JL, Schleinitz N, Suarez F, Swiader L, Taque S, Thomas C, Tournilhac O, Thumerelle C, Tron F, Vannier JP, Viallard JF.

J Clin Immunol. 2019 Oct;39(7):702-712. doi: 10.1007/s10875-019-00658-9. Epub 2019 Aug 10.

PMID:
31401750
3.

Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.

Rigaud C, Auperin A, Jourdain A, Haouy S, Couec ML, Aladjidi N, Gandemer V, Lambliotte A, Plat G, Landman-Parker J, Michon J, Leblanc T, Patte C, Minard-Colin V.

Pediatr Blood Cancer. 2019 Sep;66(9):e27873. doi: 10.1002/pbc.27873. Epub 2019 Jun 17.

PMID:
31207026
4.

Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: Reconciling biological concepts and clinical issues.

Gaudichon J, Jakobczyk H, Debaize L, Cousin E, Galibert MD, Troadec MB, Gandemer V.

Blood Rev. 2019 Jul;36:40-56. doi: 10.1016/j.blre.2019.04.003. Epub 2019 Apr 17. Review.

5.

Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study.

Gouache E, Greze V, Strullu M, Saultier P, Fenneteau O, Gandemer V, Ragu C, Auvrignon A, Boutroux H, Lapillonne H, Pasquet M, Leverger G.

Hemasphere. 2018 Oct;2(5):e141. doi: 10.1097/HS9.0000000000000141. Epub 2018 Oct 2. No abstract available.

6.

[Use of blinatumomab in children acute lymphoblastic leukemia in the Grand Ouest interregion: A chance for all].

Camuset M, Grain A, Lorton F, Minckes O, Jourdain A, Millot F, Pellier I, Gandemer V, Battisti FR.

Bull Cancer. 2019 Mar;106(3):206-215. doi: 10.1016/j.bulcan.2018.11.012. Epub 2019 Jan 11. French.

PMID:
30638898
7.

Imatinib treatment of paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (EsPhALL2010): a prospective, intergroup, open-label, single-arm clinical trial.

Biondi A, Gandemer V, De Lorenzo P, Cario G, Campbell M, Castor A, Pieters R, Baruchel A, Vora A, Leoni V, Stary J, Escherich G, Li CK, Cazzaniga G, Cavé H, Bradtke J, Conter V, Saha V, Schrappe M, Grazia Valsecchi M.

Lancet Haematol. 2018 Dec;5(12):e641-e652. doi: 10.1016/S2352-3026(18)30173-X.

PMID:
30501871
8.

Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation.

Debaize L, Jakobczyk H, Avner S, Gaudichon J, Rio AG, Sérandour AA, Dorsheimer L, Chalmel F, Carroll JS, Zörnig M, Rieger MA, Delalande O, Salbert G, Galibert MD, Gandemer V, Troadec MB.

Nucleic Acids Res. 2018 Nov 30;46(21):11214-11228. doi: 10.1093/nar/gky756.

9.

Adolescence and Socioeconomic Factors: Key Factors in the Long-Term Impact of Leukemia on Scholastic Performance-A LEA Study.

Bonneau J, Berbis J, Michel G, Vercasson C, Bertrand Y, Ansoborlo S, Dalle JH, Baruchel A, Tabone MD, Paillard C, Contet A, Poirée M, Sirvent N, Thouvenin S, Kanold J, Freycon C, Saultier P, Auquier P, Gandemer V.

J Pediatr. 2019 Feb;205:168-175.e2. doi: 10.1016/j.jpeds.2018.09.047. Epub 2018 Nov 13.

PMID:
30442413
10.

Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.

Héritier S, Barkaoui MA, Miron J, Thomas C, Moshous D, Lambilliotte A, Mazingue F, Kebaili K, Jeziorski E, Plat G, Aladjidi N, Pacquement H, Galambrun C, Brugières L, Leverger G, Mansuy L, Paillard C, Deville A, Pagnier A, Lutun A, Gillibert-Yvert M, Stephan JL, Cohen-Aubart F, Haroche J, Pellier I, Millot F, Gandemer V, Martin-Duverneuil N, Taly V, Hélias-Rodzewicz Z, Emile JF, Hoang-Xuan K, Idbaih A, Donadieu J.

Br J Haematol. 2018 Nov;183(4):608-617. doi: 10.1111/bjh.15577. Epub 2018 Nov 12.

PMID:
30421536
11.

Single-Unit versus Double-Unit Umbilical Cord Blood Transplantation in Children and Young Adults with Residual Leukemic Disease.

Balligand L, Galambrun C, Sirvent A, Roux C, Pochon C, Bruno B, Jubert C, Loundou A, Esmiol S, Yakoub-Agha I, Forcade E, Paillard C, Marie-Cardine A, Plantaz D, Gandemer V, Blaise D, Rialland F, Renard C, Seux M, Baumstarck K, Mohty M, Dalle JH, Michel G.

Biol Blood Marrow Transplant. 2019 Apr;25(4):734-742. doi: 10.1016/j.bbmt.2018.10.016. Epub 2018 Oct 29.

PMID:
30385256
12.

Clinical, virological and immunological features of HIV-positive children internationally adopted in France from 2005-2015.

Corbin V, Frange P, Veber F, Blanche S, Runel-Belliard C, Lalande M, Gandemer V, Moukagni-Pelzer M, Dollfus C, Coban D, Prouteau J, Jacomet C, Lesens O; HIV adopted children study group.

PLoS One. 2018 Sep 28;13(9):e0203438. doi: 10.1371/journal.pone.0203438. eCollection 2018. Erratum in: PLoS One. 2019 Jan 14;14(1):e0210933.

13.

[Le Bulletin du Cancer: Developing adults - children partnership].

Gandemer V, Orbach D, Pellier I.

Bull Cancer. 2018 Oct;105(10):849-850. doi: 10.1016/j.bulcan.2018.07.018. Epub 2018 Sep 20. French. No abstract available.

PMID:
30243476
14.

Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: high white blood cell count at diagnosis is the strongest prognostic factor.

Biondi A, Cario G, De Lorenzo P, Castor A, Conter V, Leoni V, Gandemer V, Pieters R, Stary J, Escherich G, Campbell M, Attarbaschi A, Li CK, Vora A, Bradtke J, Saha V, Valsecchi MG, Schrappe M.

Haematologica. 2019 Jan;104(1):e13-e16. doi: 10.3324/haematol.2018.199422. Epub 2018 Sep 13. No abstract available.

15.

Unrelated cord blood transplantation in patients with idiopathic refractory severe aplastic anemia: a nationwide phase 2 study.

Peffault de Latour R, Chevret S, Jubert C, Sirvent A, Galambrun C, Ruggeri A, Gandemer V, Cornillon J, Rialland F, Dalle JH, Forcade E, Bruno B, Paillard C, Rorlich PS, Salmon A, Fürst S, Sicre de Fontbrune F, Rubio MT, Bay JO, Mohty M, Larghero J, Gluckman E, Socié G; Francophone Society of Bone Marrow Transplantation and Cellular Therapy.

Blood. 2018 Aug 16;132(7):750-754. doi: 10.1182/blood-2018-01-829630. Epub 2018 May 14.

PMID:
29760162
16.

Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study.

Fresneau B, Orbach D, Faure-Conter C, Sudour-Bonnange H, Vérité C, Gandemer V, Pasquet M, Fasola S, Rome A, Raimbault S, Martelli H, Frappaz D, Le Teuff G, Patte C.

Eur J Cancer. 2018 May;95:11-19. doi: 10.1016/j.ejca.2018.02.029. Epub 2018 Mar 28.

PMID:
29604495
17.

Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group.

Marceau-Renaut A, Duployez N, Ducourneau B, Labopin M, Petit A, Rousseau A, Geffroy S, Bucci M, Cuccuini W, Fenneteau O, Ruminy P, Nelken B, Ducassou S, Gandemer V, Leblanc T, Michel G, Bertrand Y, Baruchel A, Leverger G, Preudhomme C, Lapillonne H.

Hemasphere. 2018 Feb 21;2(1):e31. doi: 10.1097/HS9.0000000000000031. eCollection 2018 Jan-Feb.

PMID:
31723759
18.

Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors' cohort: a comparison with controls from the French population.

Oudin C, Berbis J, Bertrand Y, Vercasson C, Thomas F, Chastagner P, Ducassou S, Kanold J, Tabone MD, Paillard C, Poirée M, Plantaz D, Dalle JH, Gandemer V, Thouvenin S, Sirvent N, Saultier P, Béliard S, Leverger G, Baruchel A, Auquier P, Pannier B, Michel G.

Haematologica. 2018 Apr;103(4):645-654. doi: 10.3324/haematol.2017.176123. Epub 2018 Jan 19.

19.

Parental reassurance concerning a feverish child: determinant factors in rural general practice.

Chapron A, Brochard M, Rousseau C, Rousseau AC, Brujean M, Fiquet L, Gandemer V.

BMC Fam Pract. 2018 Jan 9;19(1):7. doi: 10.1186/s12875-017-0686-1.

20.

Burden of Poor Health Conditions and Quality of Life in 656 Children with Primary Immunodeficiency.

Barlogis V, Mahlaoui N, Auquier P, Fouyssac F, Pellier I, Vercasson C, Allouche M, De Azevedo CB, Moshous D, Neven B, Pasquet M, Jeziorski E, Aladjidi N, Thomas C, Gandemer V, Mazingue F, Picard C, Blanche S, Michel G, Fischer A.

J Pediatr. 2018 Mar;194:211-217.e5. doi: 10.1016/j.jpeds.2017.10.029. Epub 2017 Dec 6.

PMID:
29198545
21.

Acute Myeloid Leukemia With Central Nervous System Involvement in Children: Experience From the French Protocol Analysis ELAM02.

Felix A, Leblanc T, Petit A, Nelkem B, Bertrand Y, Gandemer V, Sirvent A, Paillard C, Schmitt C, Rohrlich PS, Fenneteau O, Ragu C, Michel G, Auvrignon A, Baruchel A, Leverger G.

J Pediatr Hematol Oncol. 2018 Jan;40(1):43-47. doi: 10.1097/MPH.0000000000001034.

PMID:
29189507
22.

Better early outcome with enteral rather than parenteral nutrition in children undergoing MAC allo-SCT.

Gonzales F, Bruno B, Alarcón Fuentes M, De Berranger E, Guimber D, Behal H, Gandemer V, Spiegel A, Sirvent A, Yakoub-Agha I, Nelken B, Duhamel A, Seguy D.

Clin Nutr. 2018 Dec;37(6 Pt A):2113-2121. doi: 10.1016/j.clnu.2017.10.005. Epub 2017 Oct 12.

PMID:
29097037
23.

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.

Cazzaniga G, De Lorenzo P, Alten J, Röttgers S, Hancock J, Saha V, Castor A, Madsen HO, Gandemer V, Cavé H, Leoni V, Köhler R, Ferrari GM, Bleckmann K, Pieters R, van der Velden V, Stary J, Zuna J, Escherich G, Stadt UZ, Aricò M, Conter V, Schrappe M, Valsecchi MG, Biondi A.

Haematologica. 2018 Jan;103(1):107-115. doi: 10.3324/haematol.2017.176917. Epub 2017 Oct 27.

24.

Organizational and Managerial Resources and Quality of Care in French Pediatric Oncology Nursing.

Chevalier S, Lejeune J, Fouquereau E, Coillot H, Gillet N, Gandemer V, Michon J, Colombat P.

J Pediatr Oncol Nurs. 2017 Nov/Dec;34(6):406-413. doi: 10.1177/1043454217717238. Epub 2017 Aug 28.

PMID:
28845730
25.

Optimization of proximity ligation assay (PLA) for detection of protein interactions and fusion proteins in non-adherent cells: application to pre-B lymphocytes.

Debaize L, Jakobczyk H, Rio AG, Gandemer V, Troadec MB.

Mol Cytogenet. 2017 Jul 20;10:27. doi: 10.1186/s13039-017-0328-2. eCollection 2017.

26.

[Relapse after rhabdomyosarcoma in childhood and adolescence: Impact of an early detection on survival].

Mallebranche C, Carton M, Minard-Colin V, Desfachelle AS, Rome A, Brisse HJ, Mosseri V, Thébaud E, Pellier I, Boutroux H, Gandemer V, Corradini N, Orbach D.

Bull Cancer. 2017 Jul - Aug;104(7-8):625-635. doi: 10.1016/j.bulcan.2017.05.008. Epub 2017 Jul 4. French.

PMID:
28687117
27.

Appendicitis in a Neutropenic Patient: A Multicentric Retrospective Study.

Scarpa AA, Hery G, Petit A, Brethon B, Jimenez I, Gandemer V, Abbou S, Haouy S, Breaud J, Poiree M.

J Pediatr Hematol Oncol. 2017 Jul;39(5):365-369. doi: 10.1097/MPH.0000000000000834.

PMID:
28486259
28.

Should We Pay Attention to the Delay Before Admission to a Pediatric Intensive Care Unit for Children With Cancer? Impact on 1-Month Mortality. A Report From the French Children's Oncology Study Group, GOCE.

Fausser JL, Tavenard A, Rialland F, Le Moine P, Minckes O, Jourdain A, Tirel O, Pellier I, Gandemer V.

J Pediatr Hematol Oncol. 2017 Jul;39(5):e244-e248. doi: 10.1097/MPH.0000000000000816.

PMID:
28267086
29.

Late effects in survivors of infantile acute leukemia: a study of the L.E.A program.

Gandemer V, Bonneau J, Oudin C, Berbis J, Bertrand Y, Tabone MD, Ducassou S, Chastagner P, Brethon B, Dalle JH, Thouvenin S, Poiree M, Plantaz D, Kanold J, Sirvent N, Lutz P, Hamidou Z, Baruchel A, Leverger G, Auquier P, Michel G.

Blood Cancer J. 2017 Jan 20;7(1):e518. doi: 10.1038/bcj.2016.129. No abstract available.

30.

Combined therapy in children and adolescents with classical Hodgkin's lymphoma: A report from the SFCE on MDH-03 national guidelines.

Seror E, Donadieu J, Pacquement H, Abbou S, Lambilliotte A, Schell M, Curtillet C, Gandemer V, Pasquet M, Aladjidi N, Lutz P, Schmitt C, Deville A, Minckes O, Vanier JP, Armari-Alla C, Thomas C, Gorde-Grosjean S, Millot F, Blouin P, Garnier N, Coze C, Devoldere C, Reguerre Y, Helfre S, Claude L, Clavel J, Oberlin O, Landman-Parker J, Leblanc T.

Pediatr Hematol Oncol. 2016 Oct - Nov;33(7-8):423-437.

PMID:
27960645
31.

Cytogenetics and outcome of allogeneic transplantation in first remission of acute myeloid leukemia: the French pediatric experience.

Alloin AL, Leverger G, Dalle JH, Galambrun C, Bertrand Y, Baruchel A, Auvrignon A, Gandemer V, Ragu C, Loundou A, Bilhou-Nabera C, Lafage-Pochitaloff M, Dastugue N, Nelken B, Jubert C, Rialland F, Plat G, Pochon C, Vannier JP, Rohrlich PS, Kanold J, Lutz P, Sirvent A, Oudin C, Cuccuini W, Michel G.

Bone Marrow Transplant. 2017 Apr;52(4):516-521. doi: 10.1038/bmt.2016.293. Epub 2016 Dec 12.

PMID:
27941778
32.

[Transfer of allogeneic stem cell transplant recipients to the intensive care unit: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].

Moreau AS, Bourhis JH, Contentin N, Couturier MA, Delage J, Dumesnil C, Gandemer V, Hichri Y, Jost E, Platon L, Jourdain M, Pène F, Yakoub-Agha I.

Bull Cancer. 2016 Nov;103(11S):S220-S228. doi: 10.1016/j.bulcan.2016.09.008. Epub 2016 Nov 2. French.

PMID:
27816169
33.

Physical health conditions and quality of life in adults with primary immunodeficiency diagnosed during childhood: A French Reference Center for PIDs (CEREDIH) study.

Barlogis V, Mahlaoui N, Auquier P, Pellier I, Fouyssac F, Vercasson C, Allouche M, De Azevedo CB, Suarez F, Moshous D, Neven B, Pasquet M, Jeziorski E, Aladjidi N, Schleinitz N, Thomas C, Gandemer V, Mazingue F, Lutz P, Hermine O, Picard C, Blanche S, Michel G, Fischer A.

J Allergy Clin Immunol. 2017 Apr;139(4):1275-1281.e7. doi: 10.1016/j.jaci.2016.08.027. Epub 2016 Sep 30.

PMID:
27697497
34.

Detection of clonal heterogeneity and targetable mutations in myeloid sarcoma by high-throughput sequencing.

Pastoret C, Houot R, Llamas-Gutierrez F, Boulland ML, Marchand T, Tas P, Ly-Sunnaram B, Gandemer V, Lamy T, Roussel M, Fest T.

Leuk Lymphoma. 2017 Apr;58(4):1008-1012. doi: 10.1080/10428194.2016.1225208. Epub 2016 Sep 23. No abstract available.

PMID:
27659839
35.

Prevalence and risk factors of iron overload after hematopoietic stem cell transplantation for childhood acute leukemia: a LEA study.

Sirvent A, Auquier P, Oudin C, Bertrand Y, Bohrer S, Chastagner P, Poirée M, Kanold J, Thouvenin S, Perel Y, Plantaz D, Tabone MD, Yakouben K, Gandemer V, Lutz P, Sirvent N, Vercasson C, Berbis J, Chambost H, Leverger G, Baruchel A, Michel G.

Bone Marrow Transplant. 2017 Jan;52(1):80-87. doi: 10.1038/bmt.2016.205. Epub 2016 Sep 5.

PMID:
27595286
36.

The Impact of Donor Type on Long-Term Health Status and Quality of Life after Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Acute Leukemia: A Leucémie de l'Enfant et de L'Adolescent Study.

Visentin S, Auquier P, Bertrand Y, Baruchel A, Tabone MD, Pochon C, Jubert C, Poirée M, Gandemer V, Sirvent A, Bonneau J, Paillard C, Freycon C, Kanold J, Villes V, Berbis J, Oudin C, Galambrun C, Pellier I, Plat G, Chambost H, Leverger G, Dalle JH, Michel G.

Biol Blood Marrow Transplant. 2016 Nov;22(11):2003-2010. doi: 10.1016/j.bbmt.2016.08.004. Epub 2016 Aug 10.

37.

Metabolic syndrome in long-term survivors of childhood acute leukemia treated without hematopoietic stem cell transplantation: an L.E.A. study.

Saultier P, Auquier P, Bertrand Y, Vercasson C, Oudin C, Contet A, Plantaz D, Poirée M, Ducassou S, Kanold J, Tabone MD, Dalle JH, Lutz P, Gandemer V, Sirvent N, Thouvenin S, Berbis J, Chambost H, Baruchel A, Leverger G, Michel G.

Haematologica. 2016 Dec;101(12):1603-1610. Epub 2016 Aug 11.

38.

X-linked primary immunodeficiency associated with hemizygous mutations in the moesin (MSN) gene.

Lagresle-Peyrou C, Luce S, Ouchani F, Soheili TS, Sadek H, Chouteau M, Durand A, Pic I, Majewski J, Brouzes C, Lambert N, Bohineust A, Verhoeyen E, Cosset FL, Magerus-Chatinet A, Rieux-Laucat F, Gandemer V, Monnier D, Heijmans C, van Gijn M, Dalm VA, Mahlaoui N, Stephan JL, Picard C, Durandy A, Kracker S, Hivroz C, Jabado N, de Saint Basile G, Fischer A, Cavazzana M, André-Schmutz I.

J Allergy Clin Immunol. 2016 Dec;138(6):1681-1689.e8. doi: 10.1016/j.jaci.2016.04.032. Epub 2016 Jun 4.

PMID:
27405666
39.

BRAF Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy.

Héritier S, Emile JF, Barkaoui MA, Thomas C, Fraitag S, Boudjemaa S, Renaud F, Moreau A, Peuchmaur M, Chassagne-Clément C, Dijoud F, Rigau V, Moshous D, Lambilliotte A, Mazingue F, Kebaili K, Miron J, Jeziorski E, Plat G, Aladjidi N, Ferster A, Pacquement H, Galambrun C, Brugières L, Leverger G, Mansuy L, Paillard C, Deville A, Armari-Alla C, Lutun A, Gillibert-Yvert M, Stephan JL, Cohen-Aubart F, Haroche J, Pellier I, Millot F, Lescoeur B, Gandemer V, Bodemer C, Lacave R, Hélias-Rodzewicz Z, Taly V, Geissmann F, Donadieu J.

J Clin Oncol. 2016 Sep 1;34(25):3023-30. doi: 10.1200/JCO.2015.65.9508. Epub 2016 Jul 5.

40.

Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of age.

Rigaud C, Barkaoui MA, Thomas C, Bertrand Y, Lambilliotte A, Miron J, Aladjidi N, Plat G, Jeziorski E, Galambrun C, Mansuy L, Lutz P, Deville A, Armari-Alla C, Reguerre Y, Fraitag S, Coulomb A, Gandemer V, Leboulanger N, Moshous D, Hoang-Xuan K, Tazi A, Heritier S, Emile JF, Donadieu J.

Br J Haematol. 2016 Sep;174(6):887-98. doi: 10.1111/bjh.14140. Epub 2016 Jun 7.

PMID:
27273725
41.

Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome.

Michel G, Galambrun C, Sirvent A, Pochon C, Bruno B, Jubert C, Loundou A, Yakoub-Agha I, Milpied N, Lutz P, Marie-Cardine A, Gandemer V, Blaise D, Michallet M, Rialland F, Renard C, Oudin C, Esmiol S, Seux M, Baumstarck K, Mohty M, Rocha V, Dalle JH.

Blood. 2016 Jun 30;127(26):3450-7. doi: 10.1182/blood-2016-01-694349. Epub 2016 Apr 20.

PMID:
27099151
42.

Relapsed or Refractory Lymphoblastic Lymphoma in Children: Results and Analysis of 23 Patients in the EORTC 58951 and the LMT96 Protocols.

Michaux K, Bergeron C, Gandemer V, Mechinaud F, Uyttebroeck A, Bertrand Y; SFCE and the EORTC children leukemia group.

Pediatr Blood Cancer. 2016 Jul;63(7):1214-21. doi: 10.1002/pbc.25990. Epub 2016 Apr 1.

PMID:
27037853
43.

Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study.

Oudin C, Auquier P, Bertrand Y, Chastagner P, Kanold J, Poirée M, Thouvenin S, Ducassou S, Plantaz D, Tabone MD, Dalle JH, Gandemer V, Lutz P, Sirvent A, Villes V, Barlogis V, Baruchel A, Leverger G, Berbis J, Michel G.

Haematologica. 2016 Jun;101(6):747-56. doi: 10.3324/haematol.2015.140053. Epub 2016 Mar 11.

44.

Keep in Mind Quality of Life: Outcome of a Ten-Year Series of Post-Transplantation Early Relapses in Childhood Acute Lymphoblastic Leukemia-A Report from the Grand Ouest Oncology Study Group for Children in France.

Haro S, Tavenard A, Rialland F, Taque S, Guillerm G, Blouin P, Esvan M, Pellier I, Gandemer V.

Biol Blood Marrow Transplant. 2016 May;22(5):889-94. doi: 10.1016/j.bbmt.2016.01.025. Epub 2016 Feb 2.

45.

A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee).

Nelken B, Cave H, Leverger G, Galambrun C, Plat G, Schmitt C, Thomas C, Vérité C, Brethon B, Gandemer V, Bertrand Y, Baruchel A, Rohrlich P.

Pediatr Blood Cancer. 2016 Feb;63(2):270-5. doi: 10.1002/pbc.25751. Epub 2015 Sep 16.

PMID:
26376115
46.

CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling.

Arnaud MP, Vallée A, Robert G, Bonneau J, Leroy C, Varin-Blank N, Rio AG, Troadec MB, Galibert MD, Gandemer V.

Blood. 2015 Oct 8;126(15):1802-12. doi: 10.1182/blood-2015-02-628560. Epub 2015 Aug 28.

PMID:
26320102
47.

Invasive Fungal Infections in Pediatric Acute Myelogenous Leukemia.

Ducassou S, Rivaud D, Auvrignon A, Vérité C, Bertrand Y, Gandemer V, Leverger G.

Pediatr Infect Dis J. 2015 Nov;34(11):1262-4. doi: 10.1097/INF.0000000000000875.

PMID:
26252569
48.

Treatment of Childhood T-Cell Lymphoblastic Lymphoma-Long-Term Results of the SFOP LMT96 Trial.

Bergeron C, Coze C, Segura C, Pacquement H, Gandemer V, Ducassou S, Patte C; Société Française d'Oncologie Pédiatrique (SFOP), France.

Pediatr Blood Cancer. 2015 Dec;62(12):2150-6. doi: 10.1002/pbc.25699. Epub 2015 Aug 6.

PMID:
26248696
49.

Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.

Donadieu J, Bernard F, van Noesel M, Barkaoui M, Bardet O, Mura R, Arico M, Piguet C, Gandemer V, Armari Alla C, Clausen N, Jeziorski E, Lambilliote A, Weitzman S, Henter JI, Van Den Bos C; Salvage Group of the Histiocyte Society.

Blood. 2015 Sep 17;126(12):1415-23. doi: 10.1182/blood-2015-03-635151. Epub 2015 Jul 20.

50.

Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study.

Oudin C, Auquier P, Bertrand Y, Contet A, Kanold J, Sirvent N, Thouvenin S, Tabone MD, Lutz P, Ducassou S, Plantaz D, Dalle JH, Gandemer V, Beliard S, Berbis J, Vercasson C, Barlogis V, Baruchel A, Leverger G, Michel G.

Bone Marrow Transplant. 2015 Nov;50(11):1438-44. doi: 10.1038/bmt.2015.167. Epub 2015 Jul 20.

PMID:
26191949

Supplemental Content

Loading ...
Support Center